Upper GI Bleed on a DOAC: Resuscitation and the Timing Trade-off

He has a major upper GI bleed with hemodynamic instability - a 14 mmHg orthostatic systolic drop plus tachycardia, cool skin, and lactate 3.8 put him in at least class II–III shock. Hemoglobin 6.8 is a late and imprecise marker; the clinical exam and lactate are driving decisions right now.

First 30 minutes:

• Volume resuscitation with isotonic crystalloid in boluses with reassessment after each, while blood is being prepared. Give the blood as soon as it is available; do not chase a number with liters of saline in an actively bleeding patient.
• Type and crossmatch, and activate massive transfusion protocol if he remains unstable - he is on a factor Xa inhibitor and may need product.
• Oxygen and continuous or 1–5 minute vital signs until stable, then every 15 minutes; level of consciousness and urine output via Foley.
• Position supine with legs elevated, keep him warm, and protect the airway - he has hematemesis, a full stomach, and altered mentation risk.
• Keep him NPO, hold home antihypertensives, and avoid NSAIDs and any intramuscular injections.
• Send CBC, coags, fibrinogen, type and screen, chemistry, and lactate, and repeat the hemoglobin after resuscitation - the initial value lags the bleed.
• Notify GI with the specific instability data, not just "he's bleeding."

What tells you it's working: heart rate trending down, systolic pressure holding without repeated boluses, improving mentation and capillary refill, urine output ≥0.5 mL/kg/h, and falling lactate. A hemoglobin that stays flat while the heart rate falls is reassuring; a hemoglobin that stays flat while he stays tachycardic is not.

Apixaban: hold further doses. He took the last dose about 4 hours ago, which is recent enough that the anticoagulant effect is substantial, and his creatinine of 1.4 means clearance is reduced, prolonging the effect. For a major bleed, reversal may be indicated - either a specific reversal agent or prothrombin complex concentrate per formulary and protocol. The INR of 1.5 is not a measure of apixaban effect and must not be used to reassure anyone.

Aspirin: do not unilaterally stop it. In a patient with a prior MI, aspirin is often continued or resumed rapidly after hemostasis, and that decision belongs to GI and cardiology together. The nurse's job is to make the indication visible - "this is secondary prevention after MI" - so the decision is made with the full picture.

Nurse's role vs. prescriber's:

• You own the data: exact time of the last dose, weight, renal function, other antiplatelets and herbals, and the bleeding severity trend. Have it ready before the physician asks.
• You own the escalation: if a potentially reversible coagulopathy is not being addressed, say so plainly and document the concern and the response.
• The decision to reverse, to transfuse product, and to restart anticoagulation is a physician decision, ideally made with cardiology input and documented with reasoning. Restart timing after hemostasis is typically a matter of days, individualized to rebleeding versus thrombotic risk.

Timing: urgent endoscopy after initial resuscitation, generally within 24 hours, is the standard for most non-variceal upper GI bleeding. Truly immediate endoscopy is reserved for ongoing hemodynamic instability despite resuscitation, or for a patient who cannot be stabilized - and that patient should be in an environment with airway and blood bank support, not wheeled into a room because a slot is open. Going now, before hemostatic resuscitation, mainly adds the risk of crashing on the table.

Pre-procedure checks that matter here:

• Airway and aspiration risk: active hematemesis, a full stomach, and hypoperfusion together make deep sedation hazardous. Anticipate an anesthesia-supported or intubated approach, and have suction tested and working at the head of the bed.
• Blood products in the room before the scope goes in, with a plan for who calls for more.
• Consent and capacity: hypoperfusion and hypoxemia can impair decision-making. If capacity is questionable, follow the emergency-treatment and surrogate decision-maker policy rather than accepting a signature from whoever is nearby.
• Anticoagulation status written on the procedure record, with the last dose time and the reversal decision, so the endoscopist is operating with that information rather than discovering it afterward.
• Medication reconciliation: home antihypertensives held, no NSAIDs, and a clear plan for stress ulcer prophylaxis and post-hemostasis resumption of antithrombotics.
• Monitoring plan for recovery: he remains at risk for rebleeding for hours after successful hemostasis - serial vitals, repeated hemoglobin, and clear call parameters written in the orders.